The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT00745446 |
|
Recruitment Status :
Completed
First Posted : September 3, 2008
Last Update Posted : September 5, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Heart Disease | Procedure: Forearm Venous Occlusion Plethysmography | Not Applicable |
18 subjects healthy male volunteers will be recruited at Umeå University. In a randomised, double blind 3 way crossover trial, subjects will be exposed to filtered air, diesel exhaust (300mcg/m3) or filtered diesel exhaust for 1 hour during intermittent exercise.
2 hours following the exposure, thrombogenicity will be assessed using the Badimon chamber - an ex-vivo model of thrombosis formed under constant flow conditions.
Forearm blood flow in response to infused intra-brachial vasodilators will be measured using venous occlusion plethysmography 6 hours after the exposure.
Arterial stiffness will be measured using peripheral arterial applanation tonometry in the hour post-exposure.
Blood samples will be collected at timepoints over the 24 hours after exposure.
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 18 participants |
| Allocation: | Randomized |
| Intervention Model: | Crossover Assignment |
| Masking: | Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor) |
| Primary Purpose: | Basic Science |
| Official Title: | The Effect of a Retrofit Particle Trap on the Vascular Effects of Diesel Exhaust Inhalation |
| Study Start Date : | September 2007 |
| Actual Primary Completion Date : | February 2008 |
| Actual Study Completion Date : | February 2008 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: 1
1 hour exposure to filtered air
|
Procedure: Forearm Venous Occlusion Plethysmography
Forearm venous occlusion plethysmography with intra-arterial infusion of Acetylcholine (5-20mcg/min), bradykinin (30-300mcg/min), sodium nitroprusside (2-8mcg/min) and Verapamil (2-10 mcg/min) into non-dominant brachial artery |
|
Experimental: 2
1 hour exposure to diesel exhaust (300mcg/m3)
|
Procedure: Forearm Venous Occlusion Plethysmography
Forearm venous occlusion plethysmography with intra-arterial infusion of Acetylcholine (5-20mcg/min), bradykinin (30-300mcg/min), sodium nitroprusside (2-8mcg/min) and Verapamil (2-10 mcg/min) into non-dominant brachial artery |
|
Experimental: 3
1 hour exposure to filtered diesel exhaust
|
Procedure: Forearm Venous Occlusion Plethysmography
Forearm venous occlusion plethysmography with intra-arterial infusion of Acetylcholine (5-20mcg/min), bradykinin (30-300mcg/min), sodium nitroprusside (2-8mcg/min) and Verapamil (2-10 mcg/min) into non-dominant brachial artery |
- Forearm blood flow in response to infused intra-arterial vasodilators [ Time Frame: 6 hours post-exposure ]
- Arterial stiffness measured by applanation tonometry [ Time Frame: In the 1 hour following exposure ]
- Thrombogenicity measured using the Badimon chamber - an ex-vivo model of thrombosis under conditions of continuous flow [ Time Frame: 2 hours after the exposure ]
- Exhaled nitric oxide - a marker of pulmonary inflammation [ Time Frame: 1 hour & 6 hours after exposure ]
- Endogenous fibrinolytic capacity - measured as net release of t-PA in response to infused bradykinin [ Time Frame: 6 hours after exposure ]
- Biochemical markers of systemic inflammation [ Time Frame: Baseline, 2, 6 & 24 hours ]
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years to 35 Years (Adult) |
| Sexes Eligible for Study: | Male |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Healthy male volunteers
Exclusion Criteria:
- Intercurrent illness
- Smoking
- Significant occupational exposure to air pollution
- Regular medication usage
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00745446
| Sweden | |
| Umeå University | |
| Umeå, Västerbottens, Sweden, SE-901 87 | |
| Principal Investigator: | Anders Blomberg, MD | Umeå University |
| Responsible Party: | Dr Anders Blomberg, Umeå University |
| ClinicalTrials.gov Identifier: | NCT00745446 |
| Other Study ID Numbers: |
VOLVO 3ARM |
| First Posted: | September 3, 2008 Key Record Dates |
| Last Update Posted: | September 5, 2008 |
| Last Verified: | September 2008 |
|
Air pollution Diesel exhaust Endothelial function Vascular function |
Particle trap Thrombosis effects inhalation |
|
Respiratory Aspiration Heart Diseases Cardiovascular Diseases |
Respiration Disorders Respiratory Tract Diseases Pathologic Processes |

